One of the most significant accomplishments of the WFH in 2025 was the successful mobilization of the global community to secure landmark improvements to the World Health Organization’s (WHO) Essential Medicines List, helping expand access to safer and more effective therapies worldwide. The WFH also represented the bleeding disorders community at the 78th World Health Assembly, advocating for stronger international commitments to care and treatment.
Important achievements were also realized across the goals outlined in the WFH 2021–2025 Strategic Plan, including:
- Expanded diagnosis rates for hemophilia and von Willebrand disease worldwide
- More than 34,700 people treated through the WFH Humanitarian Aid Program
- Nearly 19,000 patients registered in the World Bleeding Disorders Registry (WBDR)
- Twenty-four countries adapted WFH treatment guidelines
Additional highlights included the publication of new clinical and educational resources, the expansion of the Shared Decision Making tool, and successful global events such as the 14th WFH Global Forum, the fourth WFH Global Summit on Women and Girls with Bleeding Disorders, and the fourth edition of the WFH Global Policy and Access Summit (GPAS).
The WFH extends its thanks to the many organizations and stakeholders who helped to make these accomplishments possible, including national member organizations (NMOs), healthcare providers, governments, and corporate partners. Each one of these stakeholders remain central to improving access to safe and sustainable care worldwide and advancing the WFH vision of Treatment for All.
To read the WFH 2025 Annual Report, please click here.